Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies

Clinical trial NCT05544968 · RECRUITING

Trial details

NCT number: NCT05544968
Sponsor: Medical College of Wisconsin
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hodgkin Disease CD30-Positive Diffuse Large B-Cell Lymphoma CD30+ Anaplastic Large Cell Lymphoma CD30+ Pleomorphic Large T-Cell Cutaneous Lymphoma CD30+ Immunoblastic Large T-Cell Cutaneous Lymphoma Leukemia Lymphoma

Start date: 2026-03-04
Primary completion: 2028-01-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.